AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Change in Working Capital
AstraZeneca PLC
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Change in Working Capital
-$3.6B
|
CAGR 3-Years
-194%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Change in Working Capital
-£1.2B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Change in Working Capital
-$13.9m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Change in Working Capital
-$357m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Change in Working Capital
-$49m
|
CAGR 3-Years
43%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Change in Working Capital
-£105.9m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-21%
|
See Also
What is AstraZeneca PLC's Change in Working Capital?
Change in Working Capital
-3.6B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Change in Working Capital amounts to -3.6B USD.
What is AstraZeneca PLC's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-9%
Over the last year, the Change in Working Capital growth was -959%. The average annual Change in Working Capital growth rates for AstraZeneca PLC have been -194% over the past three years , -14% over the past five years , and -9% over the past ten years .